
Peter Mac Research
@PeterMacRes
Followers
4K
Following
960
Media
232
Statuses
2K
Cancer-dedicated research workforce @PeterMacCC. Committed to better treatments, care and cures for cancer
Parkville, Melbourne, Australia
Joined April 2019
RT @PeterMacCC: Join Peter Mac’s Research Student Open Day to meet supervisors, chat with students & explore projects. 📅 27 Aug, 4:30pm.📍….
0
4
0
RT @PeterMacCC: $4.8M in #MRFF funding powers new genomic research at Peter Mac by A/Profs @LEForrest, @DrKaraBritt and Prof Paul James.….
0
4
0
RT @PeterMacCC: Peter Mac trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma.….
0
2
0
RT @PeterMacCC: Peter Mac’s Prof @MAF_Dawson has won the 2025 @ASH_hematology William Dameshek Prize – the first Australian to receive this….
0
1
0
RT @PeterMacRadOnc: Ground-breaking, practice-changing research from Prof Danny Rischin & Prof Sandro Porceddu @PeterMacCC and brilliant te….
0
6
0
RT @PeterMacCC: A record number of Peter Mac researchers presented at #ASCO25 — with global-impact trials, theranostics leadership, ctDNA b….
0
8
0
RT @PeterMacCC: An experimental therapy involving radioactive Terbium, and designed to seek out and kill prostate cancer cells wherever the….
petermac.org
0
5
0
RT @DrMHofman: Don't miss the first-in-human VIOLET study being presented #ASCO25 @ASCO . Monday June 2 3:00 PM New Frontiers in Prostate-S….
0
20
0
More practice changing research coming out of @PeterMacCC presented @ASCO2025. With a simultaneous publication in @NEJM 🙌.
dailynews.ascopubs.org
Adjuvant cemiplimab is associated with a significant reduction in the risk of disease recurrence in patients with high-risk CSCC after surgery and postoperative radiotherapy, according to results...
0
2
9
RT @PeterMacCC: Applications are now open for this unique opportunity to undertake a 2-year clinical fellowship based between two world lea….
0
3
0
RT @MAF_Dawson: Australia completely lacks a dedicated training program for clinician scientists. With the vision and support of VMIAL @Pet….
nature.com
Peter Mac is launching Australia’s first clinician-scientist fellowship to advance cancer care, fostering innovation and global collaboration.
0
21
0
RT @PeterMacCC: An electric first day at the 2025 #PeterMacResearch Symposium ⚡. 400+ scientists & clinicians gathered to explore Future Te….
0
4
0
RT @PeterMacCC: He's done it!! . Gamini cycled 5000kms over 42 days - crossing the entire continent from Perth to Brisbane. Crossing the f….
0
1
0
RT @PeterMacCC: With a grant from the @MarkHughesFdn, @PeterMacRadOnc's Dr Neda Haghighi will explore if using three smaller pre-surgery do….
0
5
0
RT @PeterMacCC: Congrats to A/Prof @shomgoel, has today been awarded the Gottschalk Medal from @Science_Academy!. His research is reshaping….
0
5
0
RT @PeterMacCC: Congratulations to @DrMHofman on winning the prestigious @TheRACP Eric Susman Prize for transforming prostate cancer care t….
0
5
0
RT @DrMHofman: We are seeking a clinical trial co-ordinator who wants to make a true impact. at @PeterMacCC . you’ll lead the coordinatio….
0
12
0
We’re #hiring 2 researchers to join exciting, multi-disciplinary programs within our Dawson labs. These roles are responsible for analysing large-scale data, applying best-practice bioinformatics workflows & developing innovative new methods. More:
0
0
0
RT @NatureMedicine: Targeting #GDF-15 in cancer: .Recent, early-phase trials show positive effects on two very challenging aspects of cance….
nature.com
Nature Medicine - Two recent, early-phase trials evaluating antibodies that target GDF-15 show positive effects on immunotherapy response and cachexia symptoms; further work to unravel the...
0
32
0